Optimizing(O) RIfapentine-based(RI) Regimen and shortENing(EN) the Treatment of Drug-sensitive Tuberculosis(T)
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Tuberculosis, Pulmonary
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Guiyang Public Health Clinical Center, Guiyang, Guizhou, China
Contact: Study coordinator (Cui Cai)People's Hospital of Qiandongnan, Kaili, Guizhou, China
Contact: Study coordinator (Jing Wang)The Third People's Hospital of Liupanshui, Liupanshui, Guizhou, China
Contact: Study coordinator (Chunlong Zhang)Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China
Contact: Study coordinator (Jianyong Zhang)Department of Infectious Disease, Huashan Hospital, Shanghai, Shanghai Municipality, China
People's Hospital of Zhuji, Zhejiang Province, Zhuji, Zhejiang, China
Study leads
Wenhong Zhang, PhD.
Principal Investigator
Huashan Hospital of Fudan University，Shanghai，China